Chronic inflammation in the gut increases the risk of colon cancer - the second-largest cause of cancer death in the US - by as much as 500 percent, suggests a new study.
The study identified an indicator in the physical and chemical components of a cell that could not only serve as an early warning of colon cancer but potentially be harnessed to counteract advanced forms of the disease, the researchers said.
New Biomarker Identifies Stage II Colon Cancer Patients
Using a new computer science approach, experts discovered a molecular feature that identified colon cancer patients who were most likely to remain disease-free.
Advertisement
‘A microRNA called miR-34a gives cancer stem cells the odd ability to divide asymmetrically, this process controls the cancerous stem cell population and generates a diverse set of cells.’
Tweet it Now
"A quarter of the world's population is affected by some type of gut inflammation and these patients always have a much higher chance of developing colon cancer," said lead author Xiling Shen, associate professor at Duke University in North Carolina, US.
The scientists focussed on a microRNA -- a class of naturally occurring, small non-coding ribonucleic acid (RNA) molecules -- called miR-34a that gives cancer stem cells the odd ability to divide asymmetrically. This process controls the cancerous stem cell population and generates a diverse set of cells.
![New Biomarker Predicts Who Requires Adjuvant Chemotherapy to Prevent Colon Cancer Relapse]( "New Biomarker Predicts Who Requires Adjuvant Chemotherapy to Prevent Colon Cancer Relapse")
A lack of gene expression is associated with high levels of cancer stem cell markers and this gene may help develop precise treatments for cancer.
However, the problem showed up when the mice's tissues became inflamed. Without any microRNA miR-34a, their stem cells quickly grew out of control and formed many tumour-like structures, the researchers elucidated.
Triggered to act when the gut becomes inflamed, miR-34a forces the process of asymmetrical division, helping to control normal stem cell populations, the findings, published online in the journal Cell Stem Cell, revealed. Even in the early stages of tumour growth, the microRNA remains active to keep the cancer stem cell population down.
As the cancer progresses however, its cells develop mutations that enable shutting off miR-34a, causing cells to divide into flexible hybrids that can revert back into stem cells if needed. It's this flexibility that makes late-stage cancers so difficult to eradicate, the researchers explained. Colon cancer development is intricately linked to a specific microRNA that dictates how cells divide, the study said.
Source: IANS
New Biomarker Predicts Who Requires Adjuvant Chemotherapy to Prevent Colon Cancer Relapse
A lack of gene expression is associated with high levels of cancer stem cell markers and this gene may help develop precise treatments for cancer.
Advertisement
However, the problem showed up when the mice's tissues became inflamed. Without any microRNA miR-34a, their stem cells quickly grew out of control and formed many tumour-like structures, the researchers elucidated.
Triggered to act when the gut becomes inflamed, miR-34a forces the process of asymmetrical division, helping to control normal stem cell populations, the findings, published online in the journal Cell Stem Cell, revealed. Even in the early stages of tumour growth, the microRNA remains active to keep the cancer stem cell population down.
As the cancer progresses however, its cells develop mutations that enable shutting off miR-34a, causing cells to divide into flexible hybrids that can revert back into stem cells if needed. It's this flexibility that makes late-stage cancers so difficult to eradicate, the researchers explained. Colon cancer development is intricately linked to a specific microRNA that dictates how cells divide, the study said.
Source: IANS
Novel Approach to Screen for Colon Cancer Proves Efficacious, Cost Effective
Mailing yearly stool kits, an alternative to the often-dreaded colonoscopy, has been helpful in boosting the rates of lifesaving colon cancer screening.
Advertisement
 Don’t Burn a Hole in Your Pocket! Vitamin D and Calcium Do Not Prevent Colon CancerDaily supplementation with vitamin D3, calcium or both after removal of colorectal adenomas did not significantly reduce the risk of its recurrence. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.